Synergistic effects of cyclosporin analogs--A, D, G, IMM-125--with rapamycin and/or brequinar.
Kahan
B D
BD
Department of Surgery, University of Texas Medical School, Houston 77030.
Chou
T
T
Tejpal
N
N
Wang
M
M
Chee
C
C
Stepkowski
S
S
D000818:Animals; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use; D003524:Cyclosporins / Q000494:pharmacology / Q000627:therapeutic use*; D004357:Drug Synergism; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D008213:Lymphocyte Activation; D008954:Models, Biological; D011090:Polyenes / Q000627:therapeutic use*; D020123:Sirolimus; D014181:Transplantation Immunology; D011798:Quinaldines
D001713:Biphenyl Compounds; D016572:Cyclosporine; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D011090:Polyenes; D020123:Sirolimus; C082770:IMM 125; C046943:brequinar; D011798:Quinaldines; C045571:cyclosporin G; C050026:cyclosporin D